Cargando…

Extracorporeal mesenchymal stromal cell therapy (SBI-101) in severe COVID-19 complicated by acute kidney injury

Detalles Bibliográficos
Autores principales: Teixiera, J., Atta, M.G., Noureddine, L., Nguyen, S., O’Rourke, B., Tilles, A., Bornschlegl, S., LaPointe, E., Dietz, A., Nissenson, A., Blair, A., Parekkadan, B., Barcia, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society for Cell & Gene Therapy. Published by Elsevier Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111903/
http://dx.doi.org/10.1016/S1465324921002772
_version_ 1783690587374878720
author Teixiera, J.
Atta, M.G.
Noureddine, L.
Nguyen, S.
O’Rourke, B.
Tilles, A.
Bornschlegl, S.
LaPointe, E.
Dietz, A.
Nissenson, A.
Blair, A.
Parekkadan, B.
Barcia, R.
author_facet Teixiera, J.
Atta, M.G.
Noureddine, L.
Nguyen, S.
O’Rourke, B.
Tilles, A.
Bornschlegl, S.
LaPointe, E.
Dietz, A.
Nissenson, A.
Blair, A.
Parekkadan, B.
Barcia, R.
author_sort Teixiera, J.
collection PubMed
description
format Online
Article
Text
id pubmed-8111903
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher International Society for Cell & Gene Therapy. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-81119032021-05-11 Extracorporeal mesenchymal stromal cell therapy (SBI-101) in severe COVID-19 complicated by acute kidney injury Teixiera, J. Atta, M.G. Noureddine, L. Nguyen, S. O’Rourke, B. Tilles, A. Bornschlegl, S. LaPointe, E. Dietz, A. Nissenson, A. Blair, A. Parekkadan, B. Barcia, R. Cytotherapy Article International Society for Cell & Gene Therapy. Published by Elsevier Inc. 2021-05 2021-05-11 /pmc/articles/PMC8111903/ http://dx.doi.org/10.1016/S1465324921002772 Text en Copyright © 2021 International Society for Cell & Gene Therapy. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Teixiera, J.
Atta, M.G.
Noureddine, L.
Nguyen, S.
O’Rourke, B.
Tilles, A.
Bornschlegl, S.
LaPointe, E.
Dietz, A.
Nissenson, A.
Blair, A.
Parekkadan, B.
Barcia, R.
Extracorporeal mesenchymal stromal cell therapy (SBI-101) in severe COVID-19 complicated by acute kidney injury
title Extracorporeal mesenchymal stromal cell therapy (SBI-101) in severe COVID-19 complicated by acute kidney injury
title_full Extracorporeal mesenchymal stromal cell therapy (SBI-101) in severe COVID-19 complicated by acute kidney injury
title_fullStr Extracorporeal mesenchymal stromal cell therapy (SBI-101) in severe COVID-19 complicated by acute kidney injury
title_full_unstemmed Extracorporeal mesenchymal stromal cell therapy (SBI-101) in severe COVID-19 complicated by acute kidney injury
title_short Extracorporeal mesenchymal stromal cell therapy (SBI-101) in severe COVID-19 complicated by acute kidney injury
title_sort extracorporeal mesenchymal stromal cell therapy (sbi-101) in severe covid-19 complicated by acute kidney injury
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111903/
http://dx.doi.org/10.1016/S1465324921002772
work_keys_str_mv AT teixieraj extracorporealmesenchymalstromalcelltherapysbi101inseverecovid19complicatedbyacutekidneyinjury
AT attamg extracorporealmesenchymalstromalcelltherapysbi101inseverecovid19complicatedbyacutekidneyinjury
AT noureddinel extracorporealmesenchymalstromalcelltherapysbi101inseverecovid19complicatedbyacutekidneyinjury
AT nguyens extracorporealmesenchymalstromalcelltherapysbi101inseverecovid19complicatedbyacutekidneyinjury
AT orourkeb extracorporealmesenchymalstromalcelltherapysbi101inseverecovid19complicatedbyacutekidneyinjury
AT tillesa extracorporealmesenchymalstromalcelltherapysbi101inseverecovid19complicatedbyacutekidneyinjury
AT bornschlegls extracorporealmesenchymalstromalcelltherapysbi101inseverecovid19complicatedbyacutekidneyinjury
AT lapointee extracorporealmesenchymalstromalcelltherapysbi101inseverecovid19complicatedbyacutekidneyinjury
AT dietza extracorporealmesenchymalstromalcelltherapysbi101inseverecovid19complicatedbyacutekidneyinjury
AT nissensona extracorporealmesenchymalstromalcelltherapysbi101inseverecovid19complicatedbyacutekidneyinjury
AT blaira extracorporealmesenchymalstromalcelltherapysbi101inseverecovid19complicatedbyacutekidneyinjury
AT parekkadanb extracorporealmesenchymalstromalcelltherapysbi101inseverecovid19complicatedbyacutekidneyinjury
AT barciar extracorporealmesenchymalstromalcelltherapysbi101inseverecovid19complicatedbyacutekidneyinjury